|
Nile Therapeutics, Incorporation. - Company Profile Snapshot
| Company Profile: |
Nile Therapeutics, Incorporation. |
| Ticker: |
NLTX |
| Exchanges: |
NAS |
| 2008 Sales: |
n/a |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
8 |
Business Description
Nile Therapeutics, Incorporation.. The Group's principal activity is to develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical need. This is the development stage biopharmaceutical company in the business of commercially developing innovative products for the treatment of cardiovascular diseases. It developing CD-NP as a treatment for heart failure. There are two product candidates, CD-NP and 2NTX-99. The Group's operates in United states.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
